Geneza Pharmaceuticals GP Bold 200 Lab Test Results

Introduction

Geneza Pharmaceuticals GP Bold 200 is marketed as containing 200 mg/ml of boldenone undecylenate and is presented in a 10-milliliter multidose vial. To validate its label claims and ensure product transparency, AnabolicLab procured samples of GP Bold 200 and submitted them for independent laboratory analysis.

The analysis, conducted by SIMEC AG, revealed that GP Bold 200 closely met its label claim, delivering 201.7 mg/ml of boldenone undecylenate—100.9% of the declared dosage. This demonstrates a consistent and reliable potency slightly above the stated claim. The product was also confirmed to be free from microbiological contamination. The analysis and sample submission were funded by AnabolicLab as part of its mission to promote transparency and harm reduction in the anabolic steroid market.

Product Overview

Manufacturer: Geneza Pharmaceuticals
Product Name: GP Bold 200
Active Ingredient: Boldenone Undecylenate
Batch Number: GP083CN
Expiration Date: December 2018
ISN Number: W2M5037H33DP (successfully verified on genezapharmaceuticals.com)
Delivery Method: Injectable (10 mL multidose vial, 200 mg/mL)
Specification: 200 mg/mL boldenone undecylenate (as per label claim)

Sample Acquisition and Testing

Date Purchased: Between August 1, 2016, and September 15, 2016
Source: European-based internet supplier
Product Submitted By: AnabolicLab
Analysis Paid For By: AnabolicLab
Analysis Performed By: SIMEC AG
Date Received by Lab: September 29, 2016
Date Report Completed: October 31, 2016

Testing Results

Quantitative Dosage Testing (HPLC-UV):
- Claimed Dosage: 200 mg/mL
- Measured Dosage: 201.7 mg/mL boldenone undecylenate
- Accuracy: 100.9% (slightly above label claim)
Microbiological Testing:
- Result: No microbiological contamination detected

Summary

Geneza Pharmaceuticals GP Bold 200 was determined to closely match its labeled dosage specification, delivering 201.7 mg/ml boldenone undecylenate compared to the declared 200 mg/ml. This reflects a reliable and consistent product with potency slightly above the stated claim. By funding the analysis and submitting the samples, AnabolicLab reinforces the importance of independent testing to ensure transparency and harm reduction in the anabolic steroid market.

Disclaimer: The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Geneza Pharmaceuticals GP Bold 200 lab test results on the AnabolicLab Forum.